Key features and details | |
Cat. No. | MABL-1466 |
Name | Anti-EDIII of DENV2 mAbs |
Clone No. | AFD- 2C8 |
From | Recombinant Antibody |
Isotype | Engineer antibody |
Application | crystallization, neutralizing, SPR, ELISA |
Species Reactivity | Dengue Virus |
Basic Information | |
Specificity | The antibody binds to domain III of the envelope (E) protein of Dengue virus. In particular, it recognizes the N-terminal region of EDIII (DIII-DI hinge residues 298-303) and the BC loop (residues 328-334), and residues K361, V282, E383 and P384. The antibody is serotype specific to DENV2. The E protein is a structural protein located on the viral surface and consists of three distinct domains termed EDI, EDII, and EDIII. Of these, EDIII mediates attachment to target cells, prior to internalization into host endosomes. |
Alternative Name | E-protein; DENV EDIII; Dengue envelope protein domain III; E protein domain III; EDIII; DVC-21; DV 21; DV-21; Envelope protein E |
UniProt | W5RZ25 |
Immunogen | The original antibody was generated by immunizing mice with DENV2 16681. |
Application Notes | Binding avidity/affinity of both Full length (IgG) and Fab fragments of the antibody to whole virion measured by ELISA. The crystal structure of the Fab fragment in complex with EDIII of DENV2 NGC was determined. Focus reduction neutralization assays showed highly potent neutralization of DENV2 NGC and 16681 for the antibody (IgG2a) with 50% neutralization titers in the sub-nanomolar range (50% FRNT at 0.025 nM). Pre- and postattachment neutralization assays showed the antibody is capable of significantly inhibiting infection after the virus had bound to the cells. The antibody has strong capacity to promote antibody dependent enhancement (ADE). ADE was analysed using U937 cells, the antibody demonstrated typical infection enhancement with peak titers of over 1000-fold enhancement over background and a wide range of concentrations at which enhancement occurred. |
Antibody First Published | Renner et al. Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus. Nat Immunol. 2018 Nov;19(11):1248-1256. PMID:30323338 |
Note on publication | The paper describes the generation and characterization of the antibody, which is specific for the envelope protein of Dengue virus. The antibody shows neutralizing activity, but promotes antibody dependent enhancement. |
COA Information （For reference only, actual COA shall prevail） | |
Size | 100 μg Purified antibody. |
Concentration | 1 mg/ml. |
Purification | Protein A affinity purified |
Buffer | PBS with 0.02% Proclin 300. |
Concentration | 1 mg/ml. |
Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. |
